Lyme Disease Diagnosis and Management
For patients diagnosed with Lyme disease, the recommended first-line treatments are doxycycline (100 mg twice daily for 10 days), amoxicillin (500 mg three times daily for 14 days), or cefuroxime axetil (500 mg twice daily for 14 days). 1
Diagnostic Interpretation
Your patient's test result shows "LYME DISEASE AB,SCR & RFX 0.90 0.90," which indicates a serologic test for Lyme disease antibodies. However, it's important to note that:
- Serologic testing alone is insufficient for diagnosis in early disease as antibody tests are often negative in the first 2 weeks 1
- Erythema migrans (EM) is the only manifestation of Lyme disease that allows clinical diagnosis without laboratory confirmation 1
- If EM is present, treatment should begin immediately without waiting for serologic test results 1
Treatment Algorithm
Early Localized Disease (Erythema Migrans)
Adults:
- Doxycycline 100 mg twice daily for 10 days, OR
- Amoxicillin 500 mg three times daily for 14 days, OR
- Cefuroxime axetil 500 mg twice daily for 14 days 1
Children:
- Amoxicillin 50 mg/kg/day in 3 divided doses (maximum 500 mg per dose) for 14 days, OR
- Cefuroxime axetil 30 mg/kg/day in 2 divided doses (maximum 500 mg per dose) for 14 days, OR
- Doxycycline 4 mg/kg/day in 2 divided doses (maximum 100 mg per dose) for children ≥8 years for 10 days 1
Neurologic Manifestations
- Meningitis or radiculopathy: IV ceftriaxone 2g daily for 14 days (range 10-28 days) 1
- Facial nerve palsy without CSF abnormalities: Oral regimen as for erythema migrans for 14 days 1
- Facial nerve palsy with CSF abnormalities: Treatment as for meningitis 1
Arthritis
- Initial treatment: Same oral regimens as for erythema migrans, but for 28 days 1
- Arthritis that has failed to improve or worsened: IV ceftriaxone 2g daily for 2-4 weeks 1
Important Considerations
Medication Precautions
When prescribing doxycycline, advise patients:
Doxycycline may interact with:
- Anticoagulants (may require dosage adjustment)
- Antacids containing aluminum, calcium, or magnesium
- Iron-containing preparations
- Bismuth subsalicylate
- Barbiturates, carbamazepine, and phenytoin 2
Common Pitfalls to Avoid
- Overreliance on serology: Do not delay treatment of erythema migrans while waiting for test results 1
- Extended antibiotic therapy: The IDSA strongly recommends against prolonged antibiotic therapy for patients with persistent subjective symptoms after appropriate treatment 1
- Misattributing nonspecific symptoms: "Chronic Lyme disease" without evidence of ongoing B. burgdorferi infection is not supported by evidence 1
- Inappropriate prophylaxis: Only truly high-risk tick bites meeting specific criteria should receive prophylaxis 1
- Using first-generation cephalosporins: These are not effective against Lyme disease 1
Post-Treatment Considerations
- Post-Lyme disease syndrome does not respond to additional antibiotic therapy 1
- For persistent symptoms, consider:
- Symptom-specific management
- Physical therapy for musculoskeletal complaints
- Cognitive behavioral therapy for pain management
- Evaluation for other conditions (fibromyalgia, chronic fatigue syndrome, autoimmune diseases, endocrine disorders, depression) 1
Recent research has identified piperacillin as a potential alternative treatment that eradicated B. burgdorferi at low concentrations in experimental models 3, but this has not yet been incorporated into clinical guidelines.